{"": [119, 128, 0, 129, 1206, 0, 1207, 1809, 0, 1810, 2472, 0, 2473, 2972, 0, 2973, 3606, 0], "Study Population": [3616, 8929, 0], "Laboratory Methods": [8930, 9436, 0], "Protein Expression and Purification": [9437, 9801, 0], "Abbott Architect": [9802, 10247, 0], "ELISAs": [10248, 11731, 0], "Neutralization Assays": [11732, 15648, 0], "Data Availability": [15649, 15912, 0], "METHODS": [3607, 15912, 1], "Longitudinal Plasma Samples From a Cohort of Sars-CoV-2 Infected Individuals": [15922, 16901, 0], "Dynamics of Neutralizing Antibody Titers Over Time": [16902, 19316, 0], "Dynamics of Spike Protein\u2013Binding and RBD-Binding Antibodies Over Time": [19317, 21059, 0], "RESULTS": [15913, 21059, 1], "DISCUSSION": [21060, 25237, 0], "Supplementary Data": [25238, 25570, 0]}